Topics

Drug manufacturer offers to pay NHS £8m to resolve CMA allegations of anti-competitive behaviour

06:55 EDT 15 Aug 2019 | The Pharmaceutical Journal

A drug manufacturer has offered to pay the NHS £8m to resolve concerns around allegations of anti-competitive behaviour over the supply of a prescription drug.

Original Article: Drug manufacturer offers to pay NHS £8m to resolve CMA allegations of anti-competitive behaviour

NEXT ARTICLE

More From BioPortfolio on "Drug manufacturer offers to pay NHS £8m to resolve CMA allegations of anti-competitive behaviour"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Prescription Drugs
A prescription drug (also prescription medication or prescription medicine) is a licensed medicine that is regulated by legislation to require a medical prescription before it can be obtained. The term is used to distinguish it from over-the-counter drug...